HUS is a well-known entity primarily associated with bacterial infection and is characterized by a classic triad of anemia, thrombocytopenia, and kidney injury. Its atypical form has been associated with calcineurin inhibitors and has been extensively discussed in renal transplantation. We present a case of tacrolimus-associated HUS in a pediatric heart transplant recipient, which we believe to be previously unreported in the literature.
|Original language||English (US)|
|Number of pages||2|
|State||Published - Sep 1 2016|
- calcineurin inhibitors
- heart transplantation
- hemolytic uremic syndrome